Search
Close this search box.
Search
Close this search box.

June 2026

Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL

New Clinical Data, Patient Reported Outcomes, Real-World Utilization, and Comparative-Effectiveness Models to be Featured in Four Oral and One Poster Presentation PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the

Read More

AJC Reaffirms Commitment to Cyprus at PSEKA Conference

Nicosia: Julie Fishman Rayman, Senior Vice President of Policy and Political Affairs at the American Jewish Committee (AJC), reiterated the organization’s steadfast support for Cyprus during the PSEKA (International Coordinating Committee Justice for …

Read More